Jiangsu Nhwa Pharmaceutical (002262.SZ): Tetrabromine Hydrochloride Tablets obtained drug registration certificate.

19/09/2025

Enhua Pharmaceutical (002262.SZ) announced that the company has recently received approval and issuance of chemical drugs by the National Medical Products Administration.

Jiangsu Nhwa Pharmaceutical (002262.SZ) announced that the company has recently obtained the "Drug Registration Certificate" issued by the National Medical Products Administration for the chemical drug tramadol hydrochloride tablets. Tramadol hydrochloride tablets are used for the treatment of severe acute pain in adult patients requiring opioid analgesics, as well as for the substitute treatment of acute pain that is not adequately relieved.

DETAI NEWENERGY (00559) Announces Profit Growth; Estimated annual net profit of approximately HK$30 million to HK$35 million.

INNOVENT BIO (01801): Masidudipeptide has been approved by the China National Medical Products Administration for blood sugar control in adult type 2 diabetes patients.

YURUN FOOD (01068): Chen Xiaomi appointed as company secretary and authorized representative.

DETAI NEWENERGY (00559) Announces Profit Growth; Estimated annual net profit of approximately HK$30 million to HK$35 million.

INNOVENT BIO (01801): Masidudipeptide has been approved by the China National Medical Products Administration for blood sugar control in adult type 2 diabetes patients.

YURUN FOOD (01068): Chen Xiaomi appointed as company secretary and authorized representative.